000 02118cam  2200397zi 4500
0019.944698
003CaOODSP
00520241031111735
006m     o  d f      
007cr mn|||||||||
008241030t20242024onc     ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH113-28/2024-8E-PDF
24500|aNatamycin and its associated end-use products : |bfinal decision.
264 1|aOttawa, Ontario : |bPest Management Regulatory Agency, Health Canada, |c2024.
264 4|c©2024
300 |a1 online resource (10 pages).
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aRe-evaluation decision, |x1925-1025 ; |vRVD2024-08
500 |aCover title.
500 |aIssued also in French under title: Natamycine et préparations commerciales connexes : décision finale.
500 |a"24 October 2024."
504 |aIncludes bibliographical references.
520 |a"This document presents the final re-evaluation decision for the re-evaluation of natamycin, including the response to comments received, and the required label updates. All products containing natamycin regulated under the Pest Control Products Act in Canada are subject to this re-evaluation decision"--Page 1.
650 0|aAntifungal agents|xCertification|zCanada.
650 0|aAntifungal agents|xRisk assessment|zCanada.
650 0|aAntifungal agents|xRisk mitigation|zCanada.
7101 |aCanada. |bPest Management Regulatory Agency, |eissuing body.
77508|tNatamycine et préparations commerciales connexes : |w(CaOODSP)9.944719
830#0|aRe-evaluation decision (Canada. Pest Management Regulatory Agency)|vRVD2024-08.|w(CaOODSP)9.505209
85640|qPDF|s254 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/h113-28/H113-28-2024-8-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/consumer-product-safety/reports-publications/pesticides-pest-management/decisions-updates/reevaluation-decision/2024/natamycin.html